Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Turmeric coffee and golden milk lattes are wellness drinks that may offer many health benefits due to their antioxidant and ...

The oral HER2 inhibitor zongertinib benefited patients with previously treated, HER2-mutated non-small cell lung cancer in a phase I clinical trial, according to results presented by John V. Heymach, ...

A new study links left-handedness with innovation. Researchers analysed CEOs and company data. They found left-handed CEOs ...

Substance use disorders (SUDs) accelerate biological aging in the brain through substance-specific molecular mechanisms.

Interim analysis from the first 16 patients in the standard-of-care ... and the prospect of offering these patients hope is a strong motivating factor for our team.” “These encouraging results are an ...